TFEB and Cerebral ischemia: Indeed, some publications have reported that TFEB activators and GSK-3β inhibition facilitated TFEB nuclear translocation and thus conferred neuroprotection at 24 h after cerebral ischemia/reperfusion injury (Wu et al., 2021; Zhang et al., 2022).